MatriSys Bioscience is leading the discovery and clinical development of a novel class of biopharmaceuticals to transform the treatment of chronic skin diseases. Our groundbreaking technology platform identifies beneficial bacteria derived from healthy human skin to potentially treat the millions of children and adults suffering from difficult to treat chronic skin diseases. Our lead clinical program focuses on patients with Atopic Dermatitis, we are also rapidly advancing therapeutics for Acne, Netherton and other skin disorders.
Our team is committed to addressing the unmet medical need in the dermatology space to innovate the next generation of therapeutics to reduce the use of steroids, immunosuppressants, and antibiotics.
Richard is a Distinguished Professor and the Founding Chairman of the Department of Dermatology at the UCSD School of Medicine. He is a leading medical scientist in the human immunology and skin microbiome space. Richard’s groundbreaking research discovered the existence of antimicrobial peptides in mammalian skin, revolutionizing our understanding of the function of the skin microbiome in human health and advancing our understanding of diseases including atopic dermatitis, rosacea and acne. MatriSys’ discovery platform is built upon his pioneering research at the Gallo Laboratory at the University of California San Diego. Richard has received major awards from the Society of Investigative Dermatology, the Japanese Society of Investigative Dermatology, and the European Societies of Investigative Dermatology. He has also been elected as a fellow of the American Association for the Advancement of Science, the American Association of Microbiology, the American Association of Clinical Investigation, the American Association of Professors and the American Dermatology Association. He completed his Dermatology Residency at Harvard Medical School and holds an MD and PhD from the University of Rochester School of Medicine.
We are building a team of highly motivated individuals dedicated to transforming the treatment of inflammatory skin diseases. Join our growing team!